VERA Stock Analysis: Buy, Sell, or Hold?
VERA - Vera Therapeutics, Inc. Class A Common Stock
$41.20
-1.46 (-3.42%)
▼
5d:
+1.73%
30d:
+31.8%
90d:
+1.73%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
28d
Get Alerted When VERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called VERA this week
67% bullish • 1 bearish
67% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VERA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VERA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VERA is currently trading at $41.20, which is considered extended relative to its 30-day fair value range of $32.14 to $39.88.
Technical Outlook: Technically, VERA is in a downtrend. Immediate support is located at $34.58, while resistance sits at $44.87. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: VERA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $78.00 (+89.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VERA is in a downtrend. Immediate support is located at $34.58, while resistance sits at $44.87. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: VERA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $78.00 (+89.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$32.14 -
$39.88
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 89.3% below Wall St target ($78.00)
Trading Range Analysis
30-Day Trading Range
$32.14 -
$39.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$34.58
Resistance Level
$44.87
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.84
Wall Street Target
$78.00
(+89.3%)
Share & Embed Analysis
Last updated: July 06, 2026 2:26 AM ET
Data refreshes hourly during market hours. Next update: 3:26 AM
Data refreshes hourly during market hours. Next update: 3:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Marshall Fordyce
SELL
22951 shares
2026-04-14
David Lee Johnson
SELL
2579 shares
2026-02-23
Joseph R Young
SELL
3117 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 45 HOLD |
